SCHEMBL13917362

SCHEMBL13917362

O=Cc1c(Cc2ccccc2)cnc2ccc(Br)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ CCNC P24863 1/20 0.42
▸ CDK8 P49336 1/20 0.42
▸ GABRA1 P14867 1/20 0.42
▸ GABRG2 P18507 1/20 0.42
▸ GABRB3 P28472 1/20 0.42
▸ GABRA5 P31644 1/20 0.42
▸ GABRA3 P34903 1/20 0.42
▸ GABRA2 P47869 1/20 0.42
▸ GABRA6 Q16445 1/20 0.42
▸ PIK3CD O00329 1/20 0.42
▸ PIK3R1 P27986 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ ERN1 O75460 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.38
▸ MMP1 P03956 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP13 P45452 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12277480 0.80 PRNP (0.45) HTTSMN1; SMN2LMNACCNCCDK8
SCHEMBL12345536 0.78 HTT (0.45) HTTSMN1; SMN2LMNACCNCCDK8
SCHEMBL27757810 0.75 ERN1 (0.43) HTTSMN1; SMN2LMNAERN1
SCHEMBL13362102 0.70 HTT (0.57) HTTSMN1; SMN2LMNACCNCCDK8
SCHEMBL27773753 0.69 CTRC (0.39) LMNA
SCHEMBL12277481 0.68 HTT (0.41) HTTSMN1; SMN2LMNACCNCCDK8
SCHEMBL6193855 0.68 MMP13 (0.46) MMP13
SCHEMBL529686 0.68 CYP1A2 (0.40) HTTSMN1; SMN2LMNACCNCCDK8
SCHEMBL529947 0.68 HTT (0.39) HTTSMN1; SMN2LMNACCNCCDK8
SCHEMBL28182440 0.67 BCL2 (0.40) HTTSMN1; SMN2LMNACCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7498343-B2 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-03 — — US disclosed
US-7498343-B2 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-03 — — US disclosed
Send feedback